At AstraZeneca, our commitment to people living with blood cancer drives our pursuit of scientific progress. We are exploring innovative research areas – from cell therapies to T cell engagers and beyond – through collaboration and discovery, aiming to advance the field and support the blood cancer community. Because for us, it’s personal. Behind every data point is a patient, a family, a story - and that’s what fuels our mission to transform care and bring hope to people with blood cancer around the world.
Aliya Omer, VP Global Head, Hematology Franchise and Cell Therapy, AstraZeneca
We have
196
projects in our pipeline
